177 related articles for article (PubMed ID: 28561276)
1. Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls.
Heidrich B; Vital M; Plumeier I; Döscher N; Kahl S; Kirschner J; Ziegert S; Solbach P; Lenzen H; Potthoff A; Manns MP; Wedemeyer H; Pieper DH
Liver Int; 2018 Jan; 38(1):50-58. PubMed ID: 28561276
[TBL] [Abstract][Full Text] [Related]
2. The impact of proton pump inhibitors on the intestinal microbiota in chronic hepatitis C patients.
Wellhöner F; Döscher N; Tergast TL; Vital M; Plumeier I; Kahl S; Potthoff A; Manns MP; Maasoumy B; Wedemeyer H; Cornberg M; Pieper DH; Heidrich B
Scand J Gastroenterol; 2019 Aug; 54(8):1033-1041. PubMed ID: 31361979
[No Abstract] [Full Text] [Related]
3. Eradication of Chronic HCV Infection: Improvement of Dysbiosis Only in Patients Without Liver Cirrhosis.
Wellhöner F; Döscher N; Woelfl F; Vital M; Plumeier I; Kahl S; Potthoff A; Manns MP; Pieper DH; Cornberg M; Wedemeyer H; Heidrich B
Hepatology; 2021 Jul; 74(1):72-82. PubMed ID: 33411981
[TBL] [Abstract][Full Text] [Related]
4. Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis.
Ponziani FR; Putignani L; Paroni Sterbini F; Petito V; Picca A; Del Chierico F; Reddel S; Calvani R; Marzetti E; Sanguinetti M; Gasbarrini A; Pompili M
Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1301-1311. PubMed ID: 30345704
[TBL] [Abstract][Full Text] [Related]
5. Association of Enteric Protist Blastocystis spp. and Gut Microbiota with Hepatic Encephalopathy.
Yildiz S; Doğan İ; Doğruman-Al F; Nalbantoğlu U; Üstek D; Sarzhanov F; Yildirim S
J Gastrointestin Liver Dis; 2016 Dec; 25(4):489-497. PubMed ID: 27981305
[TBL] [Abstract][Full Text] [Related]
6. Gut Dysbiosis Associated With Hepatitis C Virus Infection.
Inoue T; Nakayama J; Moriya K; Kawaratani H; Momoda R; Ito K; Iio E; Nojiri S; Fujiwara K; Yoneda M; Yoshiji H; Tanaka Y
Clin Infect Dis; 2018 Aug; 67(6):869-877. PubMed ID: 29718124
[TBL] [Abstract][Full Text] [Related]
7. HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients.
Bajaj JS; Sterling RK; Betrapally NS; Nixon DE; Fuchs M; Daita K; Heuman DM; Sikaroodi M; Hylemon PB; White MB; Ganapathy D; Gillevet PM
Aliment Pharmacol Ther; 2016 Sep; 44(6):638-43. PubMed ID: 27417456
[TBL] [Abstract][Full Text] [Related]
8. Predictors of histological activity and fibrosis in chronic Hepatitis C infection: a study from North India.
Singh S; Gupta R; Malhotra V; Sarin SK
Indian J Pathol Microbiol; 2010; 53(2):238-43. PubMed ID: 20551524
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing antibodies in patients with chronic hepatitis C and correlation to liver cirrhosis and estimated duration of infection.
Pedersen J; Lundbo LF; Krarup H; Bukh J; Weis N
J Med Virol; 2016 Oct; 88(10):1791-803. PubMed ID: 27027386
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota changes and chronic hepatitis C virus infection.
Preveden T; Scarpellini E; Milić N; Luzza F; Abenavoli L
Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):813-819. PubMed ID: 28621554
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory status in human hepatic cirrhosis.
Martínez-Esparza M; Tristán-Manzano M; Ruiz-Alcaraz AJ; García-Peñarrubia P
World J Gastroenterol; 2015 Nov; 21(41):11522-41. PubMed ID: 26556984
[TBL] [Abstract][Full Text] [Related]
12. Japan-specific subtype of hepatitis C virus genotype 1b, J subtype, has relatively low pathogenicity.
Nakano I; Fukuda Y; Katano Y; Toyoda H; Hayashi K; Kumada T; Nakano S
J Med Virol; 2001 Sep; 65(1):45-51. PubMed ID: 11505442
[TBL] [Abstract][Full Text] [Related]
13. Relationship between intestinal microbial dysbiosis and primary liver cancer.
Zhang L; Wu YN; Chen T; Ren CH; Li X; Liu GX
Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):149-157. PubMed ID: 30661942
[TBL] [Abstract][Full Text] [Related]
14. Natural history of chronic hepatitis C: genotype 1 versus genotype 6.
Seto WK; Lai CL; Fung J; Hung I; Yuen J; Young J; Wong DK; Yuen MF
J Hepatol; 2010 Sep; 53(3):444-8. PubMed ID: 20554340
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
17. Significance of toll-like receptors 2 and 4 mRNA expression in chronic hepatitis C virus infection.
Shehata MA; Abou El-Enein A; El-Sharnouby GA
Egypt J Immunol; 2006; 13(1):141-52. PubMed ID: 17974158
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological features of chronic hepatitis C infection caused by remunerated blood donors: A nearly 27-year period survey.
Tan YW; Tao Y; Liu LG; Ye Y; Zhou XB; Chen L; He C
World J Gastroenterol; 2018 Mar; 24(11):1250-1258. PubMed ID: 29568205
[TBL] [Abstract][Full Text] [Related]
19. Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis.
Ciocan D; Voican CS; Wrzosek L; Hugot C; Rainteau D; Humbert L; Cassard AM; Perlemuter G
Aliment Pharmacol Ther; 2018 Nov; 48(9):961-974. PubMed ID: 30144108
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis.
Benvegnù L; Pontisso P; Cavalletto D; Noventa F; Chemello L; Alberti A
Hepatology; 1997 Jan; 25(1):211-5. PubMed ID: 8985292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
